Malfunctions within these pathways lead to various abnormalities in CD133-positive cells, including altered self-renewal capacities, enhanced proliferation, disrupted differentiation, increased resistance to apoptosis and chemotherapy, elevated invasiveness, greater potential for metastasis, and a higher likelihood of cancer recurrence [61]. Here, PROM1 is linked to cancer.